Skip Navigation

Sharing Knowledge.

Supporting People.

Advancing Care.

About the Bronchiectasis and NTM Association

The Bronchiectasis and NTM Association is dedicated to improving the lives of people affected by bronchiectasis and NTM lung disease. The Association is committed to advancing high-quality, specialized care, research, education, support, and advocacy within the bronchiectasis and NTM lung disease communities, helping people live longer, healthier lives.

Latest Activity

Read the latest activity from our blog, press releases and BronchandNTM360social, our online community.

Latest Blog Post

Blog

What Is the Bronchiectasis and NTM Care Center Network?

This blog post was authored by Lucinda Shore and reviewed by the Bronchiectasis and NTM Content Review and Evaluation Committee.As bronchiectasis and nontuberculous mycobacterial (NTM) lung disease become more common in the U.S., getting a quick, accurate diagnosis and expert care is very important. To help meet this need, the Bronchiectasis and NTM Association created the Bronchiectasis and NTM Care Center Network (CCN).The CCN connects people to medical centers throughout the U.S. that provide expert care and treatment, high-quality education, advice, and support for those living with bronchiectasis and NTM lung disease. The CCN gives sites one of two designations:Care Center: These centers offer a clinical research program, treat hundreds of people with bronchiectasis and NTM, and provide direct access to specialists (like dietitians or psychologists) for immediate care.Clinical Associate Center (CAC): CACs provide high-quality, expert care, but may see fewer people with both conditions, may be less involved in research, and may not have access to specialists within the center.

Read More
Abstracts

Press Release

Bronchiectasis and NTM Association announces Externally-Led Patient-Focused Drug Development meeting for non-cystic fibrosis bronchiectasis

The Bronchiectasis and NTM Association today announced plans for an Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting for non-cystic fibrosis bronchiectasis (NCFB). This meeting is modeled after the Food & Drug Administration’s (FDA) PFDD public meetings. Drug developers, FDA, and other stakeholders will be in attendance.NCFB is a chronic lung disease characterized by inflammation and chronic infection in which the airways become abnormally widened, thickened, and/or scarred. Once considered rare, NCFB is now recognized more widely as awareness, research, and advances in imaging have improved understanding of the disease. Although the first FDA-approved treatment for NCFB became available in 2025, significant challenges remain. Many people still face delays in diagnosis, limited access to specialized care, and difficulties managing the disease’s daily impact.The NCFB EL-PFDD meeting will:Enhance understanding of how living with NCFB impacts daily life experiences;Capture diverse perspectives of the NCFB community to help foster timely and effective therapy development; andInform regulatory decision-making with insights on current care and treatment benefit needs.

Read More
360Social

Discussion

Pulmonologist and Infectious Disease Specialist

When Do You Need an Infectious Disease (ID) Doctor Alongside Your Pulmonologist?If you are living with Bronchiectasis and Nontuberculous Mycobacteria lung disease, you may wonder: Is my pulmonologist enough, or should I also be seeing an Infectious Disease (ID) doctor ?The answer may be both! Although pulmonologists and ID doctors work closely together, they bring different areas of expertise to your care.🫁 What Does Your Pulmonologist Do?Your pulmonologist focuses on the health of your lungs, including:• Monitoring bronchiectasis and lung function. • Managing airway clearance and mucus production. • Evaluating cough, shortness of breath, and respiratory symptoms. • Monitoring CT scans and lung disease diagnostic tests  • Managing flare ups and other respiratory complications.🦠 When Might You Need an ID Specialist?An infectious disease doctor with experience in NTM/MAC can be particularly valuable when:• You need help determining whether positive cultures represent active disease requiring treatment. • You are considering starting a multidrug antibiotic regimen. • You have drug sensitivities, allergies, or concerns about medication interactions. • You are experiencing significant medication side effects. • Your cultures remain positive despite treatment. • You have developed antibiotic resistance or need a change in treatment strategy. • You are experiencing a recurrence or relapse after completing treatment.Why Having Both Specialists MattersNTM treatment can be complicated. It often involves multiple antibiotics, prolonged treatment, regular sputum cultures, laboratory monitoring, and careful assessment of side effects.Your pulmonologist and ID doctor can collaborate to address both your respiratory health and the complexities of treating a chronic mycobacterial infection.❤️ YOU ARE YOUR OWN BEST ADVOCATE!  You deserve a healthcare team that communicates, listens to your concerns, and understands the complexities of NTM and bronchiectasis.If you are not sure whether you need an ID specialist, consider asking your pulmonologist:“Would my care benefit from a consultation with an infectious disease specialist who has specific experience treating NTM?”Not every patient needs two specialists, but for many patients, a multidisciplinary approach can make a meaningful difference.Knowledge is power. Collaboration is better care. Do you see both a pulmonologist and an infectious disease doctor? Have you found that having both perspectives has helped you navigate your NTM journey?Thank you in advance for comments that will benefit our community. :)

Read More

New Bronchiectasis Diagnoses

Approximately 70,000 adults are newly diagnosed with bronchiectasis each year in the United States. An estimated 350,000 to 500,000 adults in the U.S. currently living with the condition.

8,600+

Bronchiectasis and NTM Research Registry

The Registry connects people with research to advance care. Participants help support clinical trials and accelerate the development of new treatments.

5,100+

BronchandNTM360social Membership

Join our growing online community to find support, ask questions and connect with others.

Monthly giving is an easy and impactful

Make an Impact

Help us move our mission forward and expand trusted education, strengthen advocacy, advance research, and improve care and resources for patients, families, caregivers, and providers.

World Bronchiectasis Day

World Bronchiectasis Day

Observed annually on July 1, World Bronchiectasis Day is a global campaign designed to raise awareness of bronchiectasis.

Stay In Touch

Sign up for our newsletter for information on upcoming events, virtual meetups, new research, treatment tips, and more, delivered straight to your inbox.